Skip to main content

Perspectives

American Health & Drug Benefits: Reflections on the First 5 Years

Gary M. Owens, MD

Perspectives, Conference Highlights ADA

ADA President’s Views on Clinical Management of Type 2 Diabetes

From Asheville to Hickory: Transforming Our “Sick Care” System into a True “Health Care” Model

Daniel G. Garrett, RPh, MS, FASHP

Adapting to Market Changes: Beyond Healthcare Reform

F. Randy Vogenberg, PhD, FASHP

The Era of Personalized Medicine in Oncology: Novel Biomarkers Ushering in New Approaches to Cancer Therapy

Steve Stricker, PharmD, MS, BCOP

What Do Payers Want in Oncology Diagnostics? Insights from a National Survey of Top Commercial and Medicare Health Plans

Gene Trogan, PhD

Moving Beyond Medicare’s ACOs to Accountable Care

Murali Karamchedu, Sam Muppalla, Robert Capobianco

Perspectives, Original Research

Modeling Costs and Outcomes Associated with a Treatment Algorithm for Problem Bleeding Episodes in Patients with Severe Hemophilia A and High-Titer Inhibitors

Patrick Bonnet, PharmD, Alessandro Gringeri, MD, Edward Gomperts, MD, Cindy Anne Leissinger, MD, Roseline d’Oiron, MD, Jerome Teitel, MD, Guy Young, MD, Meg Franklin, PharmD, PhD, Bruce Ewenstein, MD, Erik Berntorp, MD, PhD

Stakeholder Perspective

Potential Cost-Savings Using a Treatment Algorithm for Problem Bleeding Episodes in Patients with Hemophilia and Inhibitors

by Hetty A. Lima, RPh, FASHP

Systematic Health Management: The Time Has Come to Do the Right Thing for Each Person

Jeff Rideout, MD, MA, FACP

Perspectives, Practice Management

Comparative Effectiveness Research in the United States: A Catalyst for Innovation

Riaz Ali, MPP, Morgan Hanger, MPP, Tanisha Carino, PhD

Page 14 of 18
Results 131 - 140 of 173